However, high circulating FGF21 levels are found in obesity and it is related to cardio-metabolic disorders including the MS, type 2 diabetes, NAFLD and coronary artery disease in human studies (37). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.